- Inicio
- Proyectos y Estudios
- A Phase 3, multicenter, double-blind, randomized, placebocontrolled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study.
A Phase 3, multicenter, double-blind, randomized, placebocontrolled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study.
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
LABORATORIOS SERVIER SL
Cita
A Phase 3, multicenter, double-blind, randomized, placebocontrolled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study. (CL3-95031-007). LABORATORIOS SERVIER SL. 2025IP:ROBERTO PEDRO DÍAZ BEVERIDGE.
Portal de investigación